Sbc Medical Group Holdings Incorporated (SBC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Sbc Medical Group Holdings Incorporated  (NASDAQ: SBC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Sbc Medical Group Holdings Incorporated's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sbc Medical Group Holdings Incorporated's ROI in the second quarter of 2026?
Sbc Medical Group Holdings Incorporated achieved a return on average invested assets (ROI) of 14.89 % in its second quarter of 2026, this is above SBC's average return on investment of 12.41%.
Sbc Medical Group Holdings Incorporated invested over the 12 months ending in its second quarter of 2026 $333 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 27 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 405 to 579.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 44.83 % 49.35 % 51.05 % 36.98 % 45.49 %
Y / Y Net Income Change TTM 48.94 % -17.16 % 83.23 % 103.13 % 80.18 %
Investment (TTM) in Millions 344 340 371 277 255
Return On Investment (TTM) 14.89 % 13.16 % 17.93 % 17.81 % 14.48 %
SBC's Overall Ranking # 579 # 405 # 164 # 154 #
Seq. Investment Change TTM 7.21 % 9.18 % 17.09 % 5.68 % 10.55 %
Seq. Net Income Change TTM 21.34 % -19.91 % 17.88 % 30.02 % -32.51 %
Net Income (TTM) in Millions 50 41 51 43 33




Return On Investment SBC's Ranking
Within: No.
Industry # 2
Sector # 28
Overall # 579

Return On Investment Statistics
High Average Low
40.37 %
12.41 %
-6.3 %
(Dec 31 2024)  







Financial Statements
Sbc Medical Group Holdings Incorporated's II. Quarter Investments $ 344 Millions SBC's Balance sheet
Sbc Medical Group Holdings Incorporated's II. Quarter Income $ 11 Millions Quarterly SBC's Income Statement
SBC's Income by Division See SBC's Income by Division


SBC Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022

Total Investments in Millions 343 205 19 119 0
Y / Y Investment Growth 67.72 % 998.95 % -84.39 % - -
Net Income in Millions 51 47 0 1 0
Y / Y Net Income Growth 9.33 % 13641.74 % -38.54 % - -
Annual Return On Investment 14.86 % 22.8 % 1.82 % 0.46 % -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 14.86 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SBC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SBC's Competitors
Subscribers only: Roi for Sbc Medical Group Holdings Incorporated's Suppliers
Subscribers only: Return On Investment for SBC's Customers

Other Ratios
SBC's Roa SBC's Inventory Turnover Ratio SBC's Growth Rates SBC's Dividend Statistics
SBC's Profitability Ratios SBC's Asset Turnover Ratio SBC's Dividend Growth
SBC's Roe SBC's Valuation Ratios SBC's Financial Strength Ratios SBC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %


Date modified: 2026-09-26T07:42:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.